Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.23 - $10.44 $550,849 - $1.1 Million
105,325 New
105,325 $575,000
Q4 2023

Feb 14, 2024

BUY
$2.8 - $4.55 $420,459 - $683,246
150,164 Added 559.56%
177,000 $722,000
Q3 2023

Nov 14, 2023

BUY
$3.77 - $6.23 $101,171 - $167,188
26,836 New
26,836 $103,000
Q3 2022

Nov 14, 2022

BUY
$5.58 - $9.04 $655,393 - $1.06 Million
117,454 Added 675.02%
134,854 $809,000
Q2 2022

Aug 15, 2022

SELL
$4.12 - $9.35 $263,680 - $598,400
-64,000 Reduced 78.62%
17,400 $112,000
Q1 2022

May 16, 2022

BUY
$5.24 - $15.58 $426,536 - $1.27 Million
81,400 New
81,400 $672,000

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $314M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.